Definition
Category A: Controlled studies show no risk: adequate, well-controlled studies in pregnant women have failed to demonstrate risk to the fetus. B: No evidence of risk in humans: either animal studies show risk, but human findings do not; or, if no adequate human studies have been performed, animal findings are negative. C: Risk cannot be ruled out: human studies are lacking and animal studies are either positive for fetal risk or lacking as well. However, potential benefits may outweigh risks. D: Positive evidence of risk: investigational or postmarketing data show risk to the fetus. Nevertheless, potential benefits may outweigh risks. X: Contraindicated in pregnancy: studies in animals or humans, or investigational or postmarketing reports, have shown fetal risks that clearly outweigh any possible benefit to the patient.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAuthor information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Preskorn, S., Dahmen, M.M., Lincoln, J. (2010). FDA Pregnancy Category. In: Stolerman, I.P. (eds) Encyclopedia of Psychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-68706-1_758
Download citation
DOI: https://doi.org/10.1007/978-3-540-68706-1_758
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-68698-9
Online ISBN: 978-3-540-68706-1
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences